Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBITDA (2016 - 2025)

Historic EBITDA for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $8.0 million.

  • Mesa Laboratories' EBITDA rose 3799.97% to $8.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $17.2 million, marking a year-over-year increase of 10672.03%. This contributed to the annual value of $16.3 million for FY2025, which is 10600.42% up from last year.
  • Latest data reveals that Mesa Laboratories reported EBITDA of $8.0 million as of Q4 2025, which was up 3799.97% from $4.7 million recorded in Q3 2025.
  • In the past 5 years, Mesa Laboratories' EBITDA registered a high of $8.0 million during Q4 2025, and its lowest value of -$271.3 million during Q1 2024.
  • In the last 5 years, Mesa Laboratories' EBITDA had a median value of $3.1 million in 2021 and averaged -$11.4 million.
  • Within the past 5 years, the most significant YoY rise in Mesa Laboratories' EBITDA was 872537.31% (2024), while the steepest drop was 5257272.73% (2024).
  • Quarter analysis of 5 years shows Mesa Laboratories' EBITDA stood at -$2.5 million in 2021, then surged by 235.43% to $3.4 million in 2022, then plummeted by 101.97% to -$67000.0 in 2023, then surged by 8725.37% to $5.8 million in 2024, then skyrocketed by 38.0% to $8.0 million in 2025.
  • Its EBITDA was $8.0 million in Q4 2025, compared to $4.7 million in Q3 2025 and $3.1 million in Q2 2025.